Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Period 1: Double Blind Period	STARTED	Placebo / Teneli + SU	98
Period 1: Double Blind Period	STARTED	Teneli / Teneli + SU	96
Period 1: Double Blind Period	COMPLETED	Placebo / Teneli + SU	95
Period 1: Double Blind Period	COMPLETED	Teneli / Teneli + SU	95
Period 1: Double Blind Period	NOT COMPLETED	Placebo / Teneli + SU	3
Period 1: Double Blind Period	NOT COMPLETED	Teneli / Teneli + SU	1
Period 2: Open-label Period	STARTED	Placebo / Teneli + SU	95
Period 2: Open-label Period	STARTED	Teneli / Teneli + SU	95
Period 2: Open-label Period	COMPLETED	Placebo / Teneli + SU	87
Period 2: Open-label Period	COMPLETED	Teneli / Teneli + SU	85
Period 2: Open-label Period	NOT COMPLETED	Placebo / Teneli + SU	8
Period 2: Open-label Period	NOT COMPLETED	Teneli / Teneli + SU	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00974090/flow